Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease
Clinical trial NCT01605513 · COMPLETED
Trial details
- NCT number
- NCT01605513
- Sponsor
- The First Hospital of Jilin University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-12-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.